This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Apr 15;67(7):937-8.

doi: 10.1097/00007890-199904150-00001.

Which immunosuppression?

D Mayer¹

Affiliations

PMID: 10221474
DOI: 10.1097/00007890-199904150-00001

Comment

Which immunosuppression?

D Mayer. Transplantation. 1999.

. 1999 Apr 15;67(7):937-8.

doi: 10.1097/00007890-199904150-00001.

Author

D Mayer¹

Affiliation

¹ Queen Elizabeth Hospital, Birmingham, England.

PMID: 10221474
DOI: 10.1097/00007890-199904150-00001

No abstract available

PubMed Disclaimer

Comment on

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.
Groth CG, Bäckman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattström C, Charpentier B. Groth CG, et al. Transplantation. 1999 Apr 15;67(7):1036-42. doi: 10.1097/00007890-199904150-00017. Transplantation. 1999. PMID: 10221490 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information